Target intelligence / Profile preview

Protein arginine methyltransferase 8 (PRMT8)

Target
PRMT8
Molecular classification
Enzyme, Membrane-bound enzyme, Post-translational modification enzyme
01

Overview

Protein arginine methyltransferase 8 (PRMT8) is a type I enzyme of the PRMT family, distinguished by its exclusive expression in the central nervous system and its dual catalytic activities—protein arginine methylation and phospholipase activity. PRMT8 anchors to the plasma membrane via a unique N-terminal myristoylation motif and regulates key neuronal processes such as dendritic growth, synapse maturation, and synaptic plasticity. In addition to these neural functions, PRMT8 has roles in embryonic stem cell pluripotency, PI3K/AKT signaling, and possibly lipid metabolism and cancer progression. Altered PRMT8 expression is linked to neurological diseases, glioblastoma, and may contribute to disease outside the brain via mutations or dysregulation. Structural studies show PRMT8 can form oligomeric assemblies, and while it shares similarities with PRMT1, its tissue localization and dual enzymatic functions set it apart within the PRMT family[1][2][3].

Other names
HRMT1L3HRMT1L4heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 4protein arginine N-methyltransferase 8HMT1 hnRNP methyltransferase-like 3arginine methyltransferase 8
02

Mechanism of action

Experimental allosteric inhibition (the “hinge region” conformation described in structural studies may offer a future target for inhibitors, but none are currently available[2])

03

Biological functions

Protein arginine methylationPhospholipase activityRegulation of dendritic growth, synapse maturation, and plasticityParticipation in PI3K/AKT signaling (in pluripotent stem cells)
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Potential for neurocognitive side effects if PRMT8 is perturbedUnknown off-target effects
06

Interacting drugs

None clearly documented in current literature
07

Biomarkers

PRMT8 transcript or protein levels in glioblastoma tissueMutational status in cancer

Beyond the preview

Go deeper on Protein arginine methyltransferase 8 (PRMT8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein arginine methyltransferase 8 (PRMT8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call